Status:
COMPLETED
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a 2-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients.
Eligibility Criteria
Inclusion
- Obese men and nonpregnant women at least 18 years of age with a specific body mass index (height and weight ratio) required by the study
Exclusion
- Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00092859
Start Date
August 1 2003
End Date
June 1 2005
Last Update
January 2 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.